CFTR and cystic fibrosis: Clevers et al. removed a small number of ISCs from patients with Cystic fibrosis (CF), modified the genes of these SCs using CRISPR/Cas9 technology, inserted normal cystic fibrosis transmembrane conductance regulator (CFTR) genes, and made them develop into organoid.